Osmotica Pharmaceuticals Plc

NASDAQ:OSMT  
2.96
-0.10 (-3.27%)
Earnings Announcements

Osmotica Pharmaceuticals Posts Qtrly Loss Per Share $0.28

Published: 08/16/2021 20:26 GMT
Osmotica Pharmaceuticals Plc (OSMT) - Reports Second Quarter 2021 Results and Provides Business Update.
Q2 Revenue $11.5 Million Versus $200,000.
Qtrly Loss per Share $0.28.
Revenue is expected to be $25.5 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $28.4 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.